Year in Review – Gastrointestinal Cancers: 2009-2010

Year in Review – Gastrointestinal Cancers: 2009-2010

Effect of Early Palliative Care on End-of-Life Care Outcomes among Patients with Metastatic NSCLC

NCIC CTG BR.19: Gefitinib Therapy for Patients with Completely Resected Non-Small Cell Lung Cancer (NSCLC)

First-Line Erlotinib with or without Chemotherapy for Never or Light Smokers with Advanced Non-Small Cell Lung Cancer (NSCLC)

First-in-Human Study of the Oral ALK Inhibitor Crizotinib for Patients with ALK-Positive Non-Small Cell Lung Cancer (NSCLC)

5-Minute Journal Club — ASCO 2010 Presentations

5-Minute Journal Club — ASCO 2010 Presentations
 
Read All Issues CME Test

Safety and Efficacy of Bosutinib in Chronic-Phase Chronic Myeloid Leukemia (CML-CP) After Resistance or Intolerance to Imatinib

Update of the ENESTnd Study: Comparison of Nilotinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia (CML-CP)

5-Minute Journal Club — ASCO 2010 Presentations

5-Minute Journal Club — ASCO 2010 Presentations
 
Read All Issues CME Test

Atlas of Molecular Oncology - Critical Pathways in Breast Cancer Treatment

Eribulin versus Treatment of Physician’s Choice for Patients with Heavily Pretreated Advanced Breast Cancer

Activity of Bevacizumab in Combination with First- and Second-Line Chemotherapy for Metastatic Breast Cancer (mBC)

Combination Anti-HER2 Therapy with Pertuzumab for Patients with HER2-Positive Metastatic Breast Cancer (mBC) Previously Treated with Trastuzumab

Effect of Targeted Intraoperative Radiation Therapy on Local Recurrence Rate in Early Breast Cancer

Syndicate content